Find Scholarly Works

Search concepts
Selected Filters
Article

The possible link between the thyroid and autoimmune liver diseases: Reply

Silveira, M. G. & Lindor, K., Sep 2010, In : Liver International. 30, 8, p. 1240-1241 2 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Liver Diseases
Thyroid Gland
16 Citations (Scopus)

The predictors of the presence of varices in patients with primary sclerosing cholangitis

Treeprasertsuk, S., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Schmoll, J., Hoskin, T., Thapa, P., Enders, F. & Lindor, K., Apr 2010, In : Hepatology. 51, 4, p. 1302-1310 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Varicose Veins
Platelet Count
Bilirubin
Endoscopy
25 Citations (Scopus)

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - A pilot study

Martin, C. R., Blanco, P. G., Keach, J. C., Petz, J. L., Zaman, M. M., Bhaskar, K. R., Cluette-Brown, J. E., Gautam, S., Sheth, S., Afdhal, N. H., Lindor, K. & Freedman, S. D., Jan 2012, In : Alimentary Pharmacology and Therapeutics. 35, 2, p. 255-265 11 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Docosahexaenoic Acids
Safety
Alkaline Phosphatase
Cystic Fibrosis Transmembrane Conductance Regulator
14 Citations (Scopus)

The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease

Charatcharoenwitthaya, P., Lindor, K. & Angulo, P., Jul 2012, In : Digestive Diseases and Sciences. 57, 7, p. 1925-1931 7 p.

Research output: Contribution to journalArticle

Liver
Enzymes
Body Weight Changes
Transaminases
Non-alcoholic Fatty Liver Disease
156 Citations (Scopus)

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

Suzuki, A., Brunt, E. M., Kleiner, D. E., Miquel, R., Smyrk, T. C., Andrade, R. J., Isabel Lucena, M., Castiella, A., Lindor, K. & Björnsson, E., Sep 2 2011, In : Hepatology. 54, 3, p. 931-939 9 p.

Research output: Contribution to journalArticle

Chemical and Drug Induced Liver Injury
Autoimmune Hepatitis
Biopsy
Liver
Cholestasis
11 Citations (Scopus)

The value of observational research in liver diseases

Lindor, R. A. & Lindor, K., Jan 2011, In : Hepatology. 53, 1, p. 1-3 3 p.

Research output: Contribution to journalArticle

Patient-Centered Care
Hepatitis C
Registries
Liver Diseases
Research Design
14 Citations (Scopus)

Treatment options for primary sclerosing cholangitis

Sinakos, E. & Lindor, K., Aug 2010, In : Expert Review of Gastroenterology and Hepatology. 4, 4, p. 473-488 16 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Ursodeoxycholic Acid
Liver Transplantation
Pathologic Constriction
Fibrosis
71 Citations (Scopus)

Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation

Risques, R. A., Lai, L. A., Himmetoglu, C., Ebaee, A., Li, L., Feng, Z., Bronner, M. P., Al-Lahham, B., Kowdley, K. V., Lindor, K., Rabinovitch, P. S. & Brentnall, T. A., Mar 1 2011, In : Cancer Research. 71, 5, p. 1669-1679 11 p.

Research output: Contribution to journalArticle

Telomere
Ulcerative Colitis
Colorectal Neoplasms
Inflammation
Telomere Shortening
37 Citations (Scopus)

Unmet clinical need in autoimmune liver diseases

Dyson, J. K., Webb, G., Hirschfield, G. M., Lohse, A., Beuers, U., Lindor, K. & Jones, D. E. J., Jan 1 2015, In : Journal of Hepatology. 62, 1, p. 208-218 11 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Liver Diseases
Therapeutics
Research
23 Citations (Scopus)

Ursodeoxycholic acid in primary sclerosing cholangitis: If withdrawal is bad, then administration is good (right?)

Tabibian, J. H. & Lindor, K., 2014, In : Hepatology. 60, 3, p. 785-788 4 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Sclerosing Cholangitis
Bile Acids and Salts
4 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
43 Citations (Scopus)

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Bile Acids and Salts
Liver Cirrhosis
25 Citations (Scopus)

Varices in early histological stage primary biliary cirrhosis

Ali, A. H., Sinakos, E., Silveira, M. G., Jorgensen, R. A., Angulo, P. & Lindor, K., Aug 2011, In : Journal of Clinical Gastroenterology. 45, 7

Research output: Contribution to journalArticle

Esophageal and Gastric Varices
Biliary Liver Cirrhosis
Varicose Veins
Bilirubin
Digestive System Endoscopy
Book
1 Citation (Scopus)

Practical Gastroenterology and Hepatology: Liver and Biliary Disease

Talley, N. J., Lindor, K. & Vargas, H. E., Aug 31 2010, Wiley-Blackwell.

Research output: Book/ReportBook

Gastroenterology
Liver Diseases
Color
Chapter

Autoimmune liver diseases

Abbas, G. & Lindor, K., Jan 2011, Autoimmune Disorders: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., p. 1-34 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Autoimmune Diseases
Biliary Liver Cirrhosis
Liver Diseases

Autoimmune Liver Diseases

Talwalkar, J. A. & Lindor, K., Aug 31 2010, Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, p. 250-260 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Autoimmune Diseases
Liver Diseases

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunoglobulin G
Sclerosing Cholangitis
Pathologic Constriction
Steroids
Retroperitoneal Fibrosis

Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis?

Sinakos, E. & Lindor, K., Jan 30 2012, Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, p. 156-158 3 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ursodeoxycholic Acid
Sclerosing Cholangitis
Inflammatory Bowel Diseases
Colorectal Neoplasms
Therapeutics

Jaundice and Pruritus: A Diagnostic Approach

Gossard, A. A. & Lindor, K., Aug 31 2010, Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, p. 87-94 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pruritus
Jaundice
Liver Diseases
Bilirubin
Skin

Primary Biliary Cirrhosis

Lindor, K. & Levy, C., 2012, Zakim and Boyer's Hepatology. Elsevier Inc., p. 738-753 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Biliary Liver Cirrhosis

Primary sclerosing cholangitis

Treeprasertsuk, S. & Lindor, K., Apr 16 2012, Textbook of Clinical Gastroenterology and Hepatology: Second Edition. Wiley-Blackwell, p. 573-579 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Survival
Ursodeoxycholic Acid
Cholangiocarcinoma

Primary Sclerosing Cholangitis

Eaton, J. E., Talwalkar, J. A. & Lindor, K., Dec 2013, The Autoimmune Diseases: Fifth Edition. Elsevier Inc., p. 925-936 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Fibrosis
Intrahepatic Bile Ducts
Extrahepatic Bile Ducts

Recurrence of primary sclerosing cholangitis after liver transplantation

Charatcharoenwitthaya, P. & Lindor, K., Jan 1 2015, Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, p. 121-134 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Recurrence
Graft Survival
Fibrosis

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ursodeoxycholic Acid
Sclerosing Cholangitis
Liver Diseases
Clinical Trials
Drug Therapy
Editorial
5 Citations (Scopus)

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

Immunoglobulins
1 Citation (Scopus)

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

Liver Abscess
Proton Pump Inhibitors
2 Citations (Scopus)

Joint society statement for elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Jan 1 2017, In : Annals of Hepatology. 16, 1, p. 6-7 2 p.

Research output: Contribution to journalEditorial

Hepatitis, Viral, Human
Preventive Health Services
Predictive Value of Tests
Medical Societies
Hepatitis
1 Citation (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
4 Citations (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
5 Citations (Scopus)

Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?

Weersma, R. K. & Lindor, K., Oct 1 2016, In : Gastroenterology. 151, 4, p. 590-593 4 p.

Research output: Contribution to journalEditorial

Sclerosing Cholangitis
Letter
3 Citations (Scopus)

Obeticholic Acid in Primary Biliary Cholangitis

Nevens, F., Lindor, K. & Jones, D. E., Nov 17 2016, In : The New England journal of medicine. 375, 20, p. e41

Research output: Contribution to journalLetter

Cholangitis
Review article
11 Citations (Scopus)

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Steatorrhea
Ursodeoxycholic Acid
Cholangiocarcinoma
1 Citation (Scopus)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma
11 Citations (Scopus)

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 1 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

Liver Diseases
Quality of Life
Pregnancy
Sclerosing Cholangitis
Cholangitis
61 Citations (Scopus)

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

Fatty Liver
Fibrosis
Therapeutics
Non-alcoholic Fatty Liver Disease
Clinical Trials

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Pruritus
Fatigue
Fibrosis
6 Citations (Scopus)

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Clinical Trials
Gastroenterology
Rare Diseases
Natural History
63 Citations (Scopus)

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

Fibrosis
Elasticity Imaging Techniques
Liver Cirrhosis
Liver
Non-alcoholic Fatty Liver Disease

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
Liver Diseases
End Stage Liver Disease
Liver Transplantation
4 Citations (Scopus)

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
End Stage Liver Disease
Cholangiocarcinoma
Inflammatory Bowel Diseases
3 Citations (Scopus)

Investigational drugs in phase II clinical trials for primary biliary cholangitis

Silveira, M. G. & Lindor, K., Oct 3 2017, In : Expert Opinion on Investigational Drugs. 26, 10, p. 1115-1121 7 p.

Research output: Contribution to journalReview article

Investigational Drugs
Phase II Clinical Trials
Cholangitis
Ursodeoxycholic Acid
Fibrosis
1 Citation (Scopus)

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
19 Citations (Scopus)

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Alkaline Phosphatase
6-ethylchenodeoxycholic acid

Primary sclerosing cholangitis in children versus adults: lessons for the clinic

Adike, A., Carey, E. J. & Lindor, K., Oct 3 2018, In : Expert Review of Gastroenterology and Hepatology. 12, 10, p. 1025-1032 8 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Pediatrics
Liver Diseases
Literature
Inflammatory Bowel Diseases
110 Citations (Scopus)

Recent advances in the development of farnesoid X receptor agonists

Ali, A. H., Carey, E. J. & Lindor, K., Jan 1 2015, In : Annals of Translational Medicine. 3, 1, 5.

Research output: Contribution to journalReview article

Bile Acids and Salts
Chenodeoxycholic Acid
Insulin Resistance
Biliary Liver Cirrhosis
Wounds and Injuries
14 Citations (Scopus)

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Damman, J. L., Rodriguez, E. A., Ali, A. H., Buness, C. W., Cox, K. L., Carey, E. J. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 886-895 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Vancomycin
Inflammatory Bowel Diseases
Therapeutics
Anti-Bacterial Agents

Targets and investigative treatments for primary biliary cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Oct 2 2016, In : Expert Opinion on Orphan Drugs. 4, 10, p. 1011-1020 10 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Phase III Clinical Trials
Phase II Clinical Trials
Short survey
25 Citations (Scopus)

Current research on the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., 2015, In : Intractable and Rare Diseases Research. 4, 1, p. 1-6 6 p.

Research output: Contribution to journalShort survey

Sclerosing Cholangitis
Research
Therapeutics
Ulcerative Colitis
Liver Transplantation